David A Potter Selected Research

David A Potter Research Topics

Disease

17	Breast Neoplasms (Breast Cancer) 05/2024 - 11/2004
13	Neoplasms (Cancer) 12/2021 - 11/2008
2	Brain Neoplasms (Brain Tumor) 09/2017 - 01/2017
1	Vascular System Injuries 05/2024
1	Atherosclerosis 05/2024
1	Inflammation (Inflammations) 02/2024
1	Neoplasm Metastasis (Metastasis) 12/2021
1	Lymphadenopathy 12/2021
1	Squamous Cell Carcinoma of Head and Neck 12/2021
1	Pathologic Complete Response 01/2021
1	Infections 01/2021
1	COVID-19 01/2021
1	Triple Negative Breast Neoplasms 01/2021
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2015
1	Pneumonia (Pneumonitis) 11/2015
1	Sepsis (Septicemia) 11/2015
1	Septic Shock (Toxic Shock Syndrome) 11/2015
1	Acute Kidney Injury (Acute Renal Failure) 11/2015
1	Carcinogenesis 04/2015
1	Obesity 02/2012
1	Lung Neoplasms (Lung Cancer) 04/2011
1	Adenocarcinoma of Lung 04/2011
1	Glioma (Gliomas) 11/2008
1	Carcinoma (Carcinomatosis) 03/2006
1	Migraine Disorders (Migraine) 11/2004

Drug/Important Bio-Agent (IBA)

6	Estrogen ReceptorsIBA 05/2024 - 03/2006
3	Hormones (Hormone)IBA 12/2023 - 03/2009
3	Biomarkers (Surrogate Marker)IBA 12/2023 - 04/2011
3	BiguanidesIBA 01/2018 - 10/2017
3	Metformin (Glucophage)FDA LinkGeneric 01/2018 - 04/2015
3	CytochromesIBA 01/2018 - 10/2017
3	AcidsIBA 01/2018 - 05/2011
3	taxaneIBA 09/2017 - 11/2015
3	etirinotecan pegolIBA 09/2017 - 11/2015
3	AnthracyclinesIBA 09/2017 - 11/2015
3	Capecitabine (Xeloda)FDA Link 09/2017 - 11/2015
2	EnzymesIBA 05/2024 - 01/2018
2	Aromatase InhibitorsIBA 05/2024 - 04/2023
2	Paclitaxel (Taxol)FDA LinkGeneric 12/2023 - 09/2017
2	COVID-19 VaccinesIBA 12/2021 - 01/2021
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2018 - 05/2011
2	Arachidonic Acid (Vitamin F)IBA 01/2018 - 10/2017
2	EicosanoidsIBA 01/2018 - 10/2017
2	Cytochrome P-450 CYP3AIBA 10/2017 - 05/2011
2	Heme (Haem)IBA 10/2017 - 10/2017
2	Ritonavir (Norvir)FDA Link 04/2011 - 03/2006
2	Small Interfering RNA (siRNA)IBA 11/2008 - 03/2006
1	Estrogens (Estrogen)FDA Link 05/2024
1	Aromatase (CYP19)IBA 05/2024
1	AndrogensIBA 05/2024
1	Immune Checkpoint InhibitorsIBA 02/2024
1	trebananibIBA 12/2023
1	Trastuzumab (Herceptin)FDA Link 12/2023
1	Messenger RNA (mRNA)IBA 12/2021
1	sapanisertibIBA 01/2021
1	VaccinesIBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	Everolimus FDA Link 01/2021
1	exemestane (Aromasin)FDA Link 01/2021
1	Fulvestrant (Faslodex)FDA Link 01/2021
1	Epoxy Compounds (Epoxides)IBA 01/2018
1	Mixed Function Oxygenases (Monooxygenases)IBA 10/2017
1	Docetaxel (Taxotere)FDA Link 09/2017
1	Gemcitabine FDA Link 09/2017
1	eribulin FDA Link 09/2017
1	Vinorelbine (Navelbine)FDA LinkGeneric 09/2017
1	ixabepilone (BMS 247550)FDA Link 09/2017
1	PolymersIBA 09/2017
1	130-nm albumin-bound paclitaxelIBA 09/2017
1	Hypoglycemic Agents (Hypoglycemics)IBA 04/2015
1	Cytochrome P-450 CYP1A1 (CYP1A1)IBA 07/2013
1	Sirolimus (Rapamycin)FDA Link 02/2012
1	Flavin-Adenine Dinucleotide (FAD)IBA 05/2011
1	Ligases (Synthetase)IBA 05/2011
1	Calcium Channels (Calcium Channel)IBA 05/2011
1	Cyclin D2IBA 05/2011
1	SurvivinIBA 04/2011
1	Protease Inhibitors (Protease Inhibitor)IBA 04/2011
1	Anastrozole (Arimidex)FDA LinkGeneric 03/2009
1	Estradiol (Delestrogen)FDA LinkGeneric 03/2009
1	Selective Estrogen Receptor Modulators (SERM)IBA 03/2009
1	Tamoxifen FDA LinkGeneric 03/2009
1	ErbB Receptors (EGF Receptor)IBA 11/2008
1	Therapeutic UsesIBA 11/2008
1	epidermal growth factor receptor VIIIIBA 11/2008
1	HIV Protease InhibitorsIBA 03/2006
1	CalpainIBA 11/2004
1	MagnesiumIBA 11/2004

Therapy/Procedure

9	Therapeutics 02/2024 - 03/2006
3	Drug Therapy (Chemotherapy) 12/2023 - 09/2017
2	Neoadjuvant Therapy 01/2021 - 01/2021
1	Investigational Therapies (Experimental Therapy) 12/2023
1	Adjuvant Chemotherapy 01/2021
1	Intravenous Infusions 11/2015